Morgan Stanley 13D and 13G filings for Royalty Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 3:15 pm Sale | 2024-09-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 36,517,159 8.200% | -4,642,590 (-11.28%) | Filing |
| 2024-02-09 3:13 pm Sale | 2023-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 41,159,749 9.200% | -2,615,649 (-5.98%) | Filing |
| 2023-02-10 3:21 pm Sale | 2022-12-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 43,775,398 9.900% | -12,235,612 (-21.85%) | Filing |
| 2022-02-10 4:43 pm Purchase | 2021-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 56,011,010 13.000% | 9,866,127 (+21.38%) | Filing |
| 2021-02-10 4:05 pm Purchase | 2021-01-29 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 46,144,883 11.900% | 22,547,596 (+95.55%) | Filing |
| 2021-02-09 4:53 pm Purchase | 2020-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 23,597,287 6.100% | 23,597,287 (New Position) | Filing |